-transparent.png){kind=logo}
Adjuvant chemotherapy allows a study of the effects of cytotoxic drugs on natural human haematopoiesis. We describe serial studies of granulopoiesis performed during and after intermittent adjuvant chemotherapy for breast cancer (adriamycin plus cyclophosphamide, given for six courses at monthly intervals). After drug administration, a sequential wave of depletion and regeneration through successive granulopoietic compartments was observed. With repeated chemotherapy, moderate neutropenia developed, and the blood CFU-C pool size became progressively reduced. After the sixth chemotherapeutic course, granulopoietic regeneration was delayed. Following discontinuation of chemotherapy, a long-lasting (greater than 200 d) reduction of the blood CFU-C pool size, together with neutropenia and reduction of marrow segmented neutrophils, was observed, suggesting a defect of granulopoiesis with persistent granulopoietic hypoplasia. In patients with expected long survival, residual bone marrow damage should be added to the list of potential late side effects of cytotoxic drug therapy.
H P Lohrmann, and
W Schreml, and
M Lang, and
M Betzler, and
T M Fliedner, and
H Heimpel
January 1998,
Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine,
H P Lohrmann, and
W Schreml, and
M Lang, and
M Betzler, and
T M Fliedner, and
H Heimpel
May 2004,
The Journal of clinical endocrinology and metabolism,
H P Lohrmann, and
W Schreml, and
M Lang, and
M Betzler, and
T M Fliedner, and
H Heimpel
April 1981,
JAMA,
H P Lohrmann, and
W Schreml, and
M Lang, and
M Betzler, and
T M Fliedner, and
H Heimpel
January 1995,
Clinical oncology (Royal College of Radiologists (Great Britain)),
H P Lohrmann, and
W Schreml, and
M Lang, and
M Betzler, and
T M Fliedner, and
H Heimpel
September 2013,
Physiotherapy,
H P Lohrmann, and
W Schreml, and
M Lang, and
M Betzler, and
T M Fliedner, and
H Heimpel
November 2023,
Translational oncology,
H P Lohrmann, and
W Schreml, and
M Lang, and
M Betzler, and
T M Fliedner, and
H Heimpel
January 2011,
Revue medicale de Liege,
H P Lohrmann, and
W Schreml, and
M Lang, and
M Betzler, and
T M Fliedner, and
H Heimpel
January 2022,
Disease markers,
H P Lohrmann, and
W Schreml, and
M Lang, and
M Betzler, and
T M Fliedner, and
H Heimpel
April 2009,
Journal of the National Cancer Institute,
H P Lohrmann, and
W Schreml, and
M Lang, and
M Betzler, and
T M Fliedner, and
H Heimpel
January 1985,
Breast cancer research and treatment,
